AMC [AMC ENTERTAINMENT] 8-K:
[]
MONT [MONTAGE TECHNOLOGY] 8-K: Montage Receives Nasdaq Extended Stay SHANGHAI, China, October
[Montage Receives Nasdaq Extended Stay SHANGHAI, China, October 23, 2014 About Montage Technology Group Limited www.montage-tech.com Montage is a global fabless provider of analog and mixed-signal semiconductor solutions currently addressing the home entertainment and cloud computing markets. In the home entertainment market, Montages technology platform enables the Company to design highly integrated end-to-end solutions with customized software for set-top boxes.] [Item 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01 99.1 Press Release dated October 23, 2014 regarding NASDAQ Extended Stay]
ONP [Orient Paper] 8-K: (Original Filing)
[Orient Paper, Inc. Announces Results of 2014 Annual Meeting of Stockholders BAODING, China, October 22, 2014 /PRNewswire/ -- Orient Paper, Inc. (NYSE MKT: ONP) ("Orient Paper" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the results of the Company's 2014 Annual Meeting of Stockholders (the "Annual Meeting"), which was held on] []
ONP [Orient Paper] 8-K: Orient Paper, Inc. Announces Results of 2014 Annual
[Orient Paper, Inc. Announces Results of 2014 Annual Meeting of Stockholders BAODING, China, October 22, 2014 /PRNewswire/ -- Orient Paper, Inc. (NYSE MKT: ONP) ("Orient Paper" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the results of the Company's 2014 Annual Meeting of Stockholders (the "Annual Meeting"), which was held on] []
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[October 23, 2014 Office of the Chief Accountant 460 Fifth Street N. W. Re : Biostar Pharmaceuticals, Inc. Dear Sirs, Clement C. W. Chan & 44342-0000 DC\81064743.1 EX-16.1 2 ex16-1.htm EX-16.1] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): October 19, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
BSPM [Biostar Pharmaceuticals] 8-K: October 23, 2014 Office of the Chief Accountant
[October 23, 2014 Office of the Chief Accountant 460 Fifth Street N. W. Re : Biostar Pharmaceuticals, Inc. Dear Sirs, Clement C. W. Chan & 44342-0000 DC\81064743.1 EX-16.1 2 ex16-1.htm EX-16.1] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): October 19, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
MONT [MONTAGE TECHNOLOGY] 8-K: (Original Filing)
[Montage Receives Nasdaq Extended Stay SHANGHAI, China, October 23, 2014 About Montage Technology Group Limited www.montage-tech.com Montage is a global fabless provider of analog and mixed-signal semiconductor solutions currently addressing the home entertainment and cloud computing markets. In the home entertainment market, Montages technology platform enables the Company to design highly integrated end-to-end solutions with customized software for set-top boxes.] [Item 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01 99.1 Press Release dated October 23, 2014 regarding NASDAQ Extended Stay]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the “Company”), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today reported that, on October 15, 2014, it received a notice from the NYSE MKT Staff indicating] []
TPI [TIANYIN PHARMACEUTICAL] 8-K: Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE
[Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the “Company”), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today reported that, on October 15, 2014, it received a notice from the NYSE MKT Staff indicating] []
